Development and Licensure of Vaccines to Prevent COVID-19

Alira Health’s Vice President, Regulatory, Olga Carroll, Ph.D., has developed a highlights whitepaper on the recent COVID-19 FDA guidance: “Development and Licensure of Vaccines to Prevent COVID-19”. This whitepaper provides an overview of best practices and key considerations to satisfy requirements for CMC, nonclinical, and clinical data through development and licensure, and for post-licensure safety evaluation.

Click the link below to access the whitepaper.